New Advances in Retinal Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 101
Special Issue Editor
Interests: retinal imaging; optical coherence tomography; drug toxicity; hydroxychloroquine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in retinal disease research and treatment have significantly improved our understanding of retinal pathophysiology and offered novel therapeutic approaches. However, critical challenges remain, such as identifying early biomarkers, developing less-invasive treatment options, and addressing global disparities in access to care.
This Special Issue aims to highlight cutting-edge research, including but not limited to imaging advancements, new pharmacological interventions, and surgical innovations. Contributions exploring the clinical diagnosis and treatment of retinal diseases, such as age-related macular degeneration, diabetic retinopathy, and inherited retinal disorders, are encouraged. This Special Issue also seeks papers addressing the integration of artificial intelligence into diagnosis and management, as well as insights into patient-reported outcomes and quality of life.
We invite researchers, clinicians, and scientists to submit original research articles, reviews, and clinical studies that tackle pressing challenges in retinal disease care and pave the way for innovative solutions.
Dr. Seong Joon Ahn
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal diseases
- advanced imaging
- biomarkers
- diabetic retinopathy
- macular degeneration
- artificial intelligence
- clinical outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
